The over active bladder diagnosis/treatment plan has a 3rd choice with the latest approval. Pfizer is distributing the drug which is made by Schwarz Pharma in Germany. Toviaz should be used with caution in patients who suffer from decreased gastrointestinal motility, such as 
those with severe constipation. The drug has already been approved and in use in Europe. BD
Toviaz, a German drug to be distributed by Pfizer Inc., received FDA approval Friday for treating the condition known as overactive bladder. The U.S. Food and Drug Administration approved the drug manufactured by Schwarz Pharma for patients who experience frequent, uncontrollable urination.
Studies showed that Toviaz reduced the incidence of such accidents. Pfizer said the condition affects up to one in six Americans and is related to involuntary contractions of the bladder. Other treatments on the market include Allergan's pill Sanctura and Watson Pharmaceutical's Oxytrol. Toviaz will be available in the first half of 2009.
0 comments :
Post a Comment